Connect with us

Stocks

Dear JMAC Stock Fans, Mark Your Calendars for March 20

Source: Shutterstock
Maxpro Capital Acquisition (NASDAQ:JMAC) is in full focus on Friday. At the high today, JMAC stock was up more than 56%, although those gains faded to a 12% move upward by the close.
Because of the wild movement and height…

Source: Shutterstock

Maxpro Capital Acquisition (NASDAQ:JMAC) is in full focus on Friday. At the high today, JMAC stock was up more than 56%, although those gains faded to a 12% move upward by the close.

Advertisement

Because of the wild movement and heightened volatility, JMAC stock also faced a trading halt. Known as a “Volatility Trading Pause,” the LUDP halt caused trading of the company to momentarily stop this morning.

That said, the large swings in the stock price come even amid a tough backdrop. Due to ongoing worries about U.S. regional banks as well as European banks, the S&P 500 is back under strong selling pressure.

Advertisement

Still, JMAC stock investors have their sights set on something else. The company plans to hold a special meeting on Monday, March 20 at 11:00 a.m. Eastern. Investors will be able to listen to the meeting live and vote.

Most notably, the company will hold a vote to approve its proposed merger with Apollomics, a late-stage clinical biopharmaceutical company. The company’s pipeline focuses on three main groups: anti-cancer enhancers, tumor inhibitors and immuno-oncology drugs.

Advertisement

What to Watch for With JMAC Stock

Aside from the vote to merge with Apollomics, investors will also have other voting measures to consider on Monday. These include “a proposal to increase the total number of authorized shares,” “a proposal to require a special resolution under Cayman Islands law” and, lastly, “a proposal to provide that directors may only be removed for cause and by a special resolution under Cayman Islands law.”

Advertisement

In a recent 8-K filing, the company also noted additional PIPE subscriptions. Specifically, it “added PIPE subscriptions totaling $23.65 million in support of its proposed merger with Apollomics, a late-stage clinical biopharmaceutical company.” Per SPAC News:

“The SPAC said $21.35 million was raised in a preferred share PIPE, convertible into 1.25 shares at $10 each with a six-month lockup. The balance of the PIPE was raised at $10 a share with one-fourth of a warrant included in each.”

Advertisement

Next week, the ongoing regional banking issues will resume and the Federal Reserve will be in the spotlight. Meanwhile, JMAC stock investors will be keenly watching the voting process play out. That will have a much bigger impact on the stock price of this name than any macro developments taking place.

On the date of publication, Bret Kenwell did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Advertisement

Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell.

More From InvestorPlace

  • Buy This $5 Stock BEFORE This Apple Project Goes Live
  • The Best $1 Investment You Can Make Today
  • It doesn’t matter if you have $500 or $5 million. Do this now.

The post Dear JMAC Stock Fans, Mark Your Calendars for March 20 appeared first on InvestorPlace.

Advertisement

InvestorPlace| InvestorPlace

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *